Cargando…
Inadequate fine-tuning of protein synthesis and failure of amino acid homeostasis following inhibition of the ATPase VCP/p97
The cellular mechanisms that control protein degradation may constitute a non-oncogenic cancer cell vulnerability and, therefore, a therapeutic target. Although this proposition is supported by the clinical success of proteasome inhibitors in some malignancies, most cancers are resistant to proteaso...
Autores principales: | Parzych, K, Chinn, T M, Chen, Z, Loaiza, S, Porsch, F, Valbuena, G N, Kleijnen, M F, Karadimitris, A, Gentleman, E, Keun, H C, Auner, H W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720905/ https://www.ncbi.nlm.nih.gov/pubmed/26720340 http://dx.doi.org/10.1038/cddis.2015.373 |
Ejemplares similares
-
The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation
por: Parzych, Katarzyna, et al.
Publicado: (2019) -
The Role of the N-Domain in the ATPase Activity of the Mammalian AAA ATPase p97/VCP
por: Niwa, Hajime, et al.
Publicado: (2012) -
P97/VCP ATPase inhibitors can rescue p97 mutation-linked motor neuron degeneration
por: Wang, F, et al.
Publicado: (2022) -
How Viruses Use the VCP/p97 ATPase Molecular Machine
por: Das, Poulami, et al.
Publicado: (2021) -
AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential
por: Vij, Neeraj
Publicado: (2008)